YCM
RNAM

Yakira Capital Management’s Avidity Biosciences RNAM Stock Holding History

Yakira Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-80,956
Closed -$5.84M – 225
2025
Q4 		$5.84M Buy
+80,956
New +$5.23M 1.96% 16

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Yakira Capital Management's RNAM Position: Q1 2026 in Review

Yakira Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 80,956 shares — an estimated $5.84M sold.

Yakira Capital Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $5.84M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Yakira Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Yakira Capital Management sold 80,956 Avidity Biosciences shares in Q1 2026, an estimated $5.84M.
  • Yakira Capital Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Yakira Capital Management's Avidity Biosciences position peaked at $5.84M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Yakira Capital Management's 13F filing for Q1 2026, filed 14 May 2026.